Profile data is unavailable for this security.
About the company
Herbalife Ltd. is a global nutrition company. The Company sells weight management; targeted nutrition; energy, sports and fitness; and other nutrition products to and through a network of independent members (Members). Its products include meal replacements, protein shakes, teas, aloes, high-protein snacks, vitamins and supplements, sports nutrition and outer nutrition products. The Company offers a range of meal replacement products, such as protein shakes, bars and soups. Its snack portfolio includes a variety of sweet, savory and creamy options, such as high protein iced coffee, protein bars, snack shakes, soups, baking mixes and others. Its Herbal Aloe Concentrate is a beverage formulated with aloe vera, which can be mixed with water, tea or protein shake. It has also developed a portfolio of dietary supplements, encompassing solutions for heart health, digestive health, immunity and others. It sells products in 95 markets across the world.
- Revenue in USD (TTM)5.06bn
- Net income in USD142.20m
- Incorporated2002
- Employees9.20k
- LocationHerbalife LtdUgland House, South Church StreetP.O. Box 309GtGRAND CAYMAN 00000Cayman IslandsCYM
- Phone+1 3453 104109600
- Fax+1 3 102587019
- Websitehttps://www.herbalife.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
YSB Inc | 2.35bn | -441.14m | 664.52m | 6.31k | -- | 2.50 | -- | 0.2831 | -25.69 | -25.69 | 47.59 | 3.24 | -- | -- | -- | 2,913,744.00 | -- | -- | -- | -- | 10.26 | -- | -18.89 | -- | 1.05 | -- | 0.1002 | -- | 18.90 | -- | -114.23 | -- | -- | -- |
Nu Skin Enterprises, Inc. | 1.97bn | 8.60m | 683.49m | 3.70k | 85.28 | 0.8329 | 8.60 | 0.3471 | 0.1622 | 0.1622 | 38.97 | 16.61 | 1.09 | 1.95 | 32.75 | 532,197.60 | 0.4739 | 6.80 | 0.5848 | 8.90 | 68.93 | 73.45 | 0.4365 | 5.26 | 1.28 | -- | 0.3797 | 62.58 | -11.53 | -5.97 | -91.80 | -41.16 | -3.63 | 1.33 |
Uniphar PLC | 2.75bn | 48.35m | 765.85m | 2.95k | 15.84 | 2.13 | 8.81 | 0.278 | 0.1641 | 0.1641 | 9.35 | 1.22 | 2.13 | 12.64 | 12.71 | -- | 3.76 | 4.12 | 6.49 | 7.24 | 15.28 | 13.61 | 1.77 | 1.87 | 0.5634 | 3.24 | 0.5338 | 10.93 | 23.30 | 12.48 | -1.69 | 38.98 | 45.53 | -- |
NanJing Pharmaceutical Co Ltd | 7.38bn | 78.28m | 812.21m | 5.06k | 10.30 | 0.9202 | -- | 0.1101 | 0.435 | 0.435 | 41.02 | 4.87 | 1.66 | 9.24 | 3.39 | 10,544,120.00 | 2.16 | 2.24 | 8.38 | 9.34 | 6.11 | 6.50 | 1.30 | 1.26 | 1.07 | 2.93 | 0.6023 | 30.50 | 11.30 | 11.76 | 17.91 | 20.71 | -8.91 | 9.24 |
Selcuk Ecza Deposu Ticaret ve Sanayi AS | 3.02bn | 6.90m | 985.84m | 6.03k | 142.86 | 2.12 | 49.78 | 0.3263 | 0.3594 | 0.3594 | 157.36 | 24.25 | 2.30 | 10.73 | 10.42 | 16,218,930.00 | 0.5255 | 3.16 | 1.41 | 8.40 | 9.38 | 9.37 | 0.2284 | 1.24 | 1.05 | -- | 0.1382 | 27.16 | 14.70 | 48.64 | -64.89 | -10.62 | 23.13 | 20.11 |
Neuca SA | 2.96bn | 32.01m | 987.45m | 4.72k | 31.49 | 4.07 | 15.54 | 0.3338 | 28.33 | 28.33 | 2,614.49 | 218.94 | 2.40 | 7.57 | 6.86 | 2,500,576.00 | 2.89 | 3.59 | 11.29 | 13.39 | 10.91 | 10.36 | 1.20 | 1.42 | 0.4933 | 3.94 | 0.3569 | 34.28 | 13.87 | 8.46 | -9.49 | 7.61 | 6.79 | 15.23 |
Herbalife Ltd | 5.06bn | 142.20m | 1.00bn | 9.20k | 7.07 | -- | 3.93 | 0.1981 | 1.42 | 1.42 | 50.51 | -10.69 | 1.83 | 2.19 | 66.70 | 550,260.90 | 5.13 | 11.30 | 8.65 | 18.70 | 76.47 | 78.43 | 2.81 | 6.02 | 0.6998 | 2.92 | 1.71 | 0.00 | -2.73 | 0.688 | -55.74 | -13.67 | 9.95 | -- |
Guangxi LiuYao Group Co Ltd | 2.83bn | 110.81m | 1.06bn | 5.16k | 9.54 | 1.17 | -- | 0.3736 | 2.21 | 2.21 | 56.44 | 17.97 | 1.02 | 7.66 | 1.96 | 3,961,076.00 | 4.36 | 5.37 | 11.45 | 12.66 | 11.26 | 11.68 | 4.27 | 4.48 | 1.26 | 6.34 | 0.5641 | 30.45 | 11.19 | 15.06 | 24.42 | 11.81 | -0.6923 | 8.57 |
DocMorris AG | 1.08bn | -130.39m | 1.38bn | 1.45k | -- | 2.47 | -- | 1.28 | -10.07 | 7.03 | 83.05 | 36.60 | 0.9863 | 11.36 | 10.50 | 667,214.10 | -11.96 | -12.92 | -15.23 | -15.74 | 20.98 | 16.84 | -12.13 | -10.87 | 1.34 | -2.39 | 0.4448 | -- | 4.13 | -4.29 | 31.29 | -- | -2.53 | -- |
Sigma Healthcare Ltd | 2.23bn | 2.94m | 1.38bn | 156.00 | 327.85 | 2.34 | 62.83 | 0.6184 | 0.004 | 0.004 | 3.34 | 0.5544 | 2.68 | 11.37 | 10.52 | -- | 0.4162 | 0.5734 | 0.625 | 0.9762 | 9.17 | 9.52 | 0.1554 | 0.2022 | 1.86 | 1.59 | 0.1354 | 184.52 | -9.16 | -3.46 | 148.98 | -34.19 | -46.55 | -21.93 |
Holder | Shares | % Held |
---|---|---|
Route One Investment Co. LPas of 31 Dec 2023 | 10.31m | 10.39% |
The Vanguard Group, Inc.as of 31 Dec 2023 | 10.01m | 10.08% |
The WindAcre Partnership LLCas of 31 Dec 2023 | 8.90m | 8.97% |
BlackRock Fund Advisorsas of 31 Dec 2023 | 6.57m | 6.61% |
Morgan Stanley & Co. LLCas of 31 Dec 2023 | 6.44m | 6.49% |
Renaissance Technologies LLCas of 31 Dec 2023 | 5.93m | 5.97% |
SSgA Funds Management, Inc.as of 31 Dec 2023 | 4.62m | 4.65% |
UBS Securities LLCas of 31 Dec 2023 | 3.68m | 3.70% |
Bronte Capital Management Pty Ltd.as of 31 Dec 2023 | 3.10m | 3.13% |
Geode Capital Management LLCas of 31 Dec 2023 | 2.26m | 2.27% |